Skip to main content

Table 2 Breakdown of annual societal cost of Alzheimer’s disease per capita based on disease severity among study population in Malaysia expressed in 2023 US dollar

From: Annual societal cost of Alzheimer’s disease in Malaysia: a micro-costing approach

Cost Categories (USD)

Mild AD (n  = 51)

Moderate AD (n  = 55)

Severe AD (n  = 29)

P value

Per capita

 
 

Mean

SD

Mean

SD

Mean

SD

 

Mean

SD

Direct cost

 DMC

539.83

385.95

580.06

485.98

677.82

585.68

0.189

579.84

468.33

 DNMC

 Transportation

57.72

71.14

81.02

123.60

52.56

56.95

0.31

66.10

94.24

 SA

231.15

825.40

766.36

2071.01

1100.67

2021.71

0.07

635.99

1718.37

 Equipment & Tools

139.11

202.02

227.69

341.76

261.85

536.98

0.26

201.57

353.69

 Consumables

98.78

222.58

191.27

536.92

554.67

885.84

0.002**

234.39

573.23

 Community Care

52.04

209.59

215.86

867.40

417.33

1369.74

0.18

197.25

854.56

 DNMC Total

578.80

1086.26

1482.20

2310.78

2387.08

2742.45

 < 0.001***

1335.30

2151.68

Indirect Cost

 Base case

5162.46

6723.89

6986.22

5141.03

8878.30

5909.35

0.024**

6703.69

6064.46

 Lower-bound SA 1

2600.35

2654.27

3907.22

2465.75

4613.90

2493.29

0.003**

3565.32

2649.19

 Lower-bound SA 2

5657.83

3342.09

7757.77

3352.74

7838.71

3397.34

0.018**

6981.85

3490.36

 Upper-bound SA

10,743.78

8381.12

14,196.60

8325.18

15,741.14

9725.33

0.043**

13,223.99

8832.02

Societal cost

 Base case

6281.10

6879.83

9048.47

5706.84

11,943.19

6954.17

0.001**

8618.83

6740.79

 Lower-bound SA 1

3718.98

3004.63

5969.48

3422.66

7678.80

3740.74

 < 0.001***

5486.48

3652.15

 Lower-bound SA 2

6776.47

3789.97

9820.02

3986.35

10,903.61

4391.07

 < 0.001***

8903.00

4327.23

 Upper-bound SA

11,862.42

8656.07

16,258.86

8666.48

18,806.04

10,611.18

0.003**

15,145.15

9447.97

  1. Remarks: DMC Direct medical cost, DNMC Direct non-medical cost, IDC Indirect cost, SA Sensitivity analysis; Base case analysis: Opportunity cost approach without supervision time; upper-bound SA estimates include supervision cost in opportunity cost approach; lower-bound SA 1 estimate valued IDC via replacement cost approach without supervision cost while lower bound SA 2 estimates valued IDC via replacement cost approach including supervision cost. P value for comparison of differences in means across AD severity groups using ANOVA; * denotes statistical significance of p < 0.05; ** denotes statistical significance of p < 0.01; *** denotes statistical significance of p < 0.001